Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction

• Հիմնական հեղինակներ: Junquan Song (Հեղինակ), Runyu Yang (Հեղինակ), Rongyuan Wei (Հեղինակ), Yue Du (Հեղինակ), Pengcheng He (Հեղինակ), Xiaowen Liu (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: BMC, 2022-05-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

Abstract Background Receptor-interacting protein kinase 2 (RIPK2, also known as RIP2) was reported to be associated with bacterial infections as well as inflammatory responses. However, the role of RIPK2 in prognosis and immunotherapy response is yet to be elucidated in human pan-cancer. Methods In...